Jim Brod­er­ick reels in a $100M Se­ries B to ex­plore a 'new and big' an­gle of im­mune reg­u­la­tion

When Jim Brod­er­ick launched Mass­a­chu­setts-based Palleon Phar­ma­ceu­ti­cals in 2015, he had an of­fice in Cam­bridge’s Kendall Square, a bit of seed mon­ey, and a blank …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER